About Prenetics Limited

Prenetics is a leading genomics and precision oncology company dedicated to transforming patient care through advanced genomic and molecular technologies. Our new business focus is on precision oncology, specifically on early detection and treatment. We recently acquired ACT Genomics, the only Asia-based company to receive FDA clearance, has enabled us to expand our capabilities and offer comprehensive cancer solutions to patients worldwide.